We are conducting a clinical research study for people who have Alzheimer’s disease. This study will evaluate a new investigational drug.

You may be eligible if you:

• Are between 60 and 85 years old
• Are diagnosed with Alzheimer’s disease
• Have a body mass index between 18.0 and 32.0 kg/m²
• Are able to complete MRI and PET scans

There are additional criteria to meet to qualify for this study. For volunteers who qualify for our study, all study-related procedures, study drug, and medical exams will be provided at no cost. Qualified volunteers will also receive a stipend for time and travel. No health insurance is required to participate.

For more information call

(904) 730-0166

Or sign up below and our office will call you!

Read the latest posts by our expert clinical staff!

Eosinophilic asthma is a type of asthma that is characterized by high levels of eosinophils in the airways. Eosinophils are a type of white blood cell that are involved in the body’s immune response to allergens and other triggers. When eosinophils are activated, they release inflammatory chemicals that can cause damage to the airways, leading to asthma symptoms.

Symptoms of eosinophilic asthma include wheezing, coughing, shortness of breath, and chest tightness. These symptoms may be more severe than those of other types of asthma and may not respond as well to traditional asthma treatments like inhaled corticosteroids.

For more information about clinical trials call:

(904) 730-0166

Or sign up below and our office will call you!

Read the latest posts by our expert clinical staff!